Proteoglycan metabolism was evaluated in megakaryocytes and platelets from guinea pigs fed a 1% cholesterol diet for 3 or 7 weeks. The animals were injected with a single dose of ["SJsulfate at the end of the feeding period, and megakaryocytes and platelets were isolated after 3 hours and then daily for 4 days thereafter. Proteoglycans were extracted from the cells of each animal and analyzed by ion-exchange chromatography, gel filtration, and electrophoresis. The maximal labeling of platelets occurred 2 days after [ 
M
egakaryocyte size has been shown to be increased in cholesterol-fed guinea pigs 1 and rabbits 2 and in humans suffering from myocardial infarction and sudden cardiac death. 3 -4 Platelets from cholesterol-fed guinea pigs 1 and from patients with cardiac disease 3 -4 were also larger than normal. A hallmark of thrombocytopenia is a substantial increase in both megakaryocyte and platelet size. These findings suggest that hypercholesterolemia or other conditions relevant to myocardial infarction might produce a state of stimulated megakaryocytopoiesis that could be analogous in some way to that induced by thrombocytopenia. Another characteristic of thrombocytopenia is thought to be an acceleration in the rate of megakaryocyte maturation and platelet production. Changes in the rate of platelet production in experimentally induced thrombocytopenia have been measured by labeling the platelets in vivo with a single injection of pSJsulfate, 5 which labels proteoglycans and sulfated proteins. The injected radiolabeled material serves as a pulse label for the megakaryocytes. The proteoglycans and sulfated proteins are synthesized essentially only by the megakaryocytes, and the labeled molecules appear in the platelets only as the platelets are released to the circulation by the megakaryocytes. In normal animals, the labeling of platelets is maximal at 3 days after administration of the cohort label. In animals made thrombocytopenic by removal of platelets by exchange transfusion, 5 maximal platelet labeling occurs at 2 days. The more rapid accumulation of radiolabel in the platelets of thrombocytopenic animals has been interpreted as a thrombocytopenia-induced acceleration of megakaryocyte maturation and platelet production. The increased labeling presumably reflects the increased megakaryocyte mass.
Our previous work has demonstrated that platelets contain several metabolically and functionally distinct proteoglycans and that proteoglycans with different characteristics are synthesized at different stages of megakaryocyte maturation. 6 This study was undertaken to determine whether the observed increase in megakaryocyte size associated with dietinduced hypercholesterolemia 1 produced an accel- eration of sulfate labeling of platelets suggestive of stimulated thrombocytopoiesis, and if so, whether specific sulfated proteoglycans were affected differently. Our strategy was identical to that used in our study of normal animals. 6 The guinea pigs were injected with a single dose of pSJsulfate, and megakaryocytes and platelets were isolated over a period of 4 days for analysis of radiolabeled proteoglycans. Molecules that appeared earliest in platelets would have been synthesized by the most mature megakaryocytes, and molecules that appeared later in platelets would have been synthesized by the younger megakaryocytes.
Methods

Materials
Sepharose CL-6B and DEAE-Sephacel chromatography media were purchased from Pharmacia, Piscataway, N.J.; electrophoresis supplies, from BioRad, Richmond, Calif.; pSJsulfate, from ICN Radiochemicals, Costa Mesa, Calif.; and chondroitin sulfate, chondroitinase ABC, chondrosulfatases, ultrapure guanidine HCl, ultrapure urea, and Ecolume scintillation fluid, from ICN Biochemicals, Costa Mesa, Calif. En 3 hance was obtained from New England Nuclear, Boston, Mass.
Animals and Cell Preparations
Male Hartley guinea pigs (300-400 g) were purchased from Ace, Boyertown, Pa. The animals were fed a diet containing 1% cholesterol in Purina guinea pig chow, which was prepared for us as pellets by Purina, St. Louis, Mo., as previously described. 1 Control animals were fed regular Purina guinea pig chow. The weight gain in cholesterol-fed animals was similar to that of controls as previously described. 1 The animals were maintained on the cholesterolenriched diet for 3 or 7 weeks. Fifteen animals were used for each feeding period. At the end of the feeding period, the animals were injected with 5 mCi/kg Na 2 35 SO 4 , and three animals were killed at 3 hours and at 1, 2, 3, and 4 days after the injection. The animals were fed the cholesterol-enriched diet during the radiolabeling period.
Blood was obtained by cardiac puncture into a syringe containing l/10th volume of acid-citrate-dextrose anticoagulant. The animals were anesthetized with ketamine/acepromazine for blood collection and were killed by injection of T-61 euthanasia solution from Hoechst-Roussel, Agri-Vet, North Somerville, N.J. Platelet-rich plasma was obtained by centrifugation, and platelets were washed as described previously. 1 Platelets were counted on a Baker Model MK4/HC platelet counter, Baker Diagnostics, Bethlehem, Pa., and contamination was determined on a hemacytometer by phase-contrast microscopy. We obtained 2X10 9 platelets from each guinea pig, and the entire platelet pellet was used for proteoglycan analysis. Contamination was less than 1/100,000. Megakaryocytes were obtained from the marrow of the long bones by density gradient centrifugation and velocity sedimentation as described previously.
Cells were counted by phase-contrast microscopy and a hemacytometer. We obtained 3 to 6x 10 5 megakaryocytes/guinea pig at 3 weeks and 2 to 5x10''megakaryocytes/guinea pig at 7 weeks. Purity was 85-90% by cell number, which represents 98% purity by cell mass. 8 The amount of radioactivity incorporated into platelets and megakaryocytes was determined by taking an aliquot of the washed cell suspensions for liquid scintillation counting.
Plasma Cholesterol Determination
Plasma cholesterol was determined using a reagent set from Sigma Chemical Co., St. Louis, Mo. Corrections were made for the volume of anticoagulant. Cholesterol-fed animals had total serum cholesterol values of 132±64 mg/dl (mean±SD). Normal guinea pigs of comparable size had a mean value of about 42 mg/dl total cholesterol. Both the standard cholesterol solutions and human serum, which had been evaluated by the clinical laboratory, were used as controls.
Proteogfycan Analysis
The platelet and megakaryocyte proteoglycans were solubilized by vigorously pipetting the cells into 8 M urea/50 mM Tris HC1/0.1 M NaCl/0.2% Triton X-100 (pH 8.0). 6 The proteoglycan extracts were prepared separately from the cells from each animal and were analyzed individually. The extracts were applied directly to a DEAE-Sephacel column that had been equilibrated in the same buffer but without Triton X-100. The proteins were eluted with 8 M urea/50 mM Tris HC1/0.1 M NaCl (pH 8.0) and then 
-sulfate (C-4-S) and chondroitin-6-sidfate (C-6-S). Identical results were obtained at 7 weeks.
X-100. The purified proteoglycans were analyzed by Sepharose CL-6B chromatography 9 or by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
-
10 Proteoglycans from at least 5x10" platelets or 3 x 10 5 megakaryocytes were used for each column and for the gels. Glycosaminoglycans were released from the proteoglycans by treatment with mild alkaline borohydride (0.05 M NaOH/1 M NaBH*) for 18 hours at 45°C. U The glycosaminoglycans were analyzed by PAGE in a Tris/borate/EDTA buffer system as described by Min and Cowman. 12 The glycosaminoglycans were visualized with Alcian Blue, and the radioactive material was identified by fluorography after treatment of the gel with En 3 hance. Figure 1 shows the total incorporation of radioactivity per cell for megakaryocytes and platelets at 3 and 7 weeks after cholesterol feeding, as determined by counting aliquots of cell suspensions, and incorporation of radioactivity specifically into proteoglycans as determined by the amount of radioactivity recovered in the proteogh/can-containing fractions from the DEAE-Sephacel column. The maximal whole-cell labeling of platelets for both sets of experiments was reached 2 days after the [^S^ulfate injection. The whole-cell labeling of platelets at 3 hours was due entirely to the presence of free pS^ulfate (see Figure 2 ). This phenomenon was noted earlier in an in vivo study of rat platelets 13 and in our study of normal guinea pig platelets and megakaryocytes. 6 We do not know whether the [^SJsulfate had adhered nonspecifically to the cell surface or had been incorporated into the platelets. Likewise, the maximal labeling of platelet proteoglycans also occurred at 2 days. The difference between the total labeling and the proteoglycan labeling curves is accounted for primarily by labeling of sulfated proteins. We had previously reported extensive incorporation of radioactivity into sulfated proteins in normal animals. After 3 weeks of cholesterol feeding, the proportion of radioactivity in sulfated proteins in all 15 animals was about 50% higher relative to proteoglycans in normal animals; equal amounts of sulfoprotein-associated radioactivity were found in the 0.1 M and 0.23 M NaQ eluates from the DEAE-Sephacel column, whereas in controls, the 0.1 M NaCl eluate contained 80-90% of the sulfoprotein radioactivity. However, at 7 weeks, the ratio between these two fractions was normal for all 15 animals. We have no explanation for this finding. Figure 2 shows the Sepharose CL-6B patterns of total labeling of platelets at 3 weeks after cholesterol feeding. Similar to that of controls, there was virtually no radiolabel in macromolecules in platelets at 3 hours after the injection. Virtually all the radiolabel was found in the V, of the column and was most likely free [-"SJsulfate. At 1 day, the peak that contained the proteoglycans appeared at Kav 0. 
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FIGURE 6. Fluorogmm of proteogfycans from the CHAPS eluate from DEAE-Sephacel column. Proteogfycans were elided with 4 M guanidine HCl/2% CHAPS/50 mM sodium acetate and chwmatographed on a 4-10% sodium dodecyl sulfate-pofyacrylamide electrophoresis gel, which was then treated with Enhance for fluorography. Each lane represents material obtained from a single animal Numbers at left represent molecular weight markers xlO' 3 . CHAPS, 3-[(3-cholamidopropyl) -dimethylammonio]-l-propanesulfonate.
animals the Kav of this peak had shifted to progressively higher molecular weight from 2 to 4 days and was 0.1 at 4 days. 6 In addition, a peak of approximately Kav 0.4 appeared in platelets at maximal levels at 1 day, much earner than in controls, where this peak was maximal at 3 days 6 ; the material in this peak elutes from the DEAE-Sephacel column with 0.1 M and 0.23 M NaCl and in the V o of a Sephadex G-25 column; therefore, this material represents sulfated proteins rather than proteoglycans. At 7 weeks, the shapes of the major peaks were the same as those at 3 weeks, except that the Kav 0.4 peak was smaller relative to the major peak. Figure 3 shows the labeling profiles of megakaryocytes on the Sepharose CL-6B column. The labeled megakaryocyte macromolecules eluted as a broad peak at 3 hours, and only the lowest molecular weight portion of this peak was lost during the first day, as had been shown previously for controls. 6 This material accounts for the low molecular weight (Kav 0.2) proteoglycan that appears in the platelets at 1 day (Figure 2) . The subsequent decrease in the magnitude of the major peak over the next 2 days occurred in a symmetrical fashion, consistent with the symmetry of the platelet proteoglycan curve during that time.
The Sepharose CL-6B column profiles of the purified proteoglycans from the 4 M guanidine HC1 eluates of the DEAE-Sephacel column from the platelets are shown in Figure 4 . The data shown are for 3 weeks, but the results were the same at 7 weeks. The shapes of these curves reflect the shapes of the higher Kav portion of the Sepharose CL-6B elution profiles from the whole-cell extracts. Unlike controls, 6 there was essentially no change in the size profile of the proteoglycans from days 2 to 4.
The glycosaminoglycan chains released from the proteoglycans of the 4 M guanidine HC1 eluate from the platelets of 3-week-cholesterol-fed animals are shown in Figure 5 . The size of the glycosaminoglycan chains was increased relative to controls as judged by their migration relative to glycosaminoglycan standards of chondroitin-4-sulfate and chondroitin-6-sulfate. In controls, the glycosaminoglycan chains migrated nearly along the most heavily stained region of the chondroitin-4-sulfate standard 6 ; in the cholesterol-fed animals, the size range was more similar to the higher M r chondroitin-6-sulfate standard. As in the control animals, only the lowest molecular weight glycosaminoglycans were labeled at 1 day after the injection. However, at 2 days, most of this material was absent, and only the higher M r glycosaminoglycans were present; the glycosaminoglycan labeling profiles were identical at 2, 3, and 4 days. In contrast, in control platelets 6 there was no apparent loss of the lowest molecular weight glycosaminoglycans until 3 days after the [ 35 S]sulfate injection. Thus, the pattern of disappearance of the small proteoglycan was different in the cholesterol-fed animals from that of the controls. The same pattern was seen at both 3 and 7 weeks.
The large proteoglycan from the 4 M guanidine HCl/2% CHAPS fraction, which we identified in control guinea pigs, was present in all animals fed the high-cholesterol diet and migrated, as did those from controls, at the top of the 4-10% gradient gel and in the stacking gel. As in controls, this proteoglycan was not present in significant amounts in platelets until 2 days after the injection (Figure 6 ). In contrast to the cholesterol-induced changes in glycosaminoglycan length in the major proteoglycan fraction described above, the glycosaminoglycans from this large proteoglycan were unaffected by the cholesterol feeding and migrated on the gels similarly to those from controls ( Figure 7 ). 
Discussion
This study has demonstrated that ingestion of a cholesterol-containing diet is associated with changes in proteoglycan metabolism in megakaryocytes and platelets of guinea pigs. The maximal labeling of platelets occurred 2 days after the [^SJsulfate injection. This phenomenon, combined with the rapid increase in megakaryocyte size and megakaryocyte and platelet protein content per cell 1 induced by cholesterol feeding, suggested that the diet had induced a state analogous to stimulated thrombopoiesis. The gradual increase in mean ^S-labeled proteoglycan size that was seen in platelets and megakaryocytes of control animals between 2-4 days was not observed in the cholesterol-fed animals. This would suggest that changes in proteoglycan size associated with normal maturation of guinea pig megakaryocytes 6 are abolished by cholesterol feeding. The mean glycosaminoglycan chain length of the proteoglycans from the 4 M guanidine HQ fraction from the DEAE-Sephacel column was increased but not that of the proteoglycans that eluted from DEAE-Sephacel with 4 M guanidine HO/2% CHAPS. Thus, the effect of cholesterol feeding on glycosaminoglycan chain length was selective for the different proteoglycans.
The mechanisms for the changes in proteoglycan metabolism in megakaryocytes from cholesterol-fed animals are not understood. Changes in proteogrycans are thought to occur in atherosclerotic plaques in humans as well as in animals subjected to experimentally induced atherosclerosis, 14 - 18 and the underlying mechanisms for these changes likewise have not been determined. It is possible that certain aspects of the biochemical basis for these alterations may be common to vessel wall cells and megakaryocytes. We can only speculate at this point about the significance of the changes in proteoglycan metabolism in megakaryocytes for megakaryocyte maturation and ultimately for platelet function. Proteogrycans are thought to be localized in the megakaryocyte a-granules and platelet membrane demarcation system, and in the platelet cr-granules and plasma membrane (reviewed in Reference 19) . Changes in megakaryocyte proteoglycan metabolism could affect 1) the development of the a-granules, resulting in changes in the rate or degree of secretion of a-granule contents either from megakaryocytes into the bone marrow or from platelets into the circulation or 2) the development of the demarcation membranes of the megakaryocyte or as-yet-not-understood properties of the platelet plasma membrane.
Many studies have presented evidence that platelet reactivity is altered in patients with hypercholesterolemia or atherosclerosis 20 
"
27 and in animals fed high-cholesterol or high-fat diets 28 " 30 (reviewed in Reference 31). However, no convincing evidence has been obtained that in vivo changes in the lipid content or lipid metabolism of the platelets can account for their altered reactivity. 31 Thus, the molecular basis for the changes in platelet behavior has not been established. Our preliminary data (B.P. Schick, unpublished observations) suggest that reactivity of platelets to collagen but not to ADP is altered in cholesterol-fed animals. We speculate that changes in the metabolism of the sulfated macromolecules of megakaryocytes and platelets could be involved in the changes observed in platelet behavior in hypercholesterolemia.
